Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05356182 · ClinicalTrials.gov registry record · NA
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
A NA study of Medical Oncology and Integrative Oncology, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05356182: Recruiting NA study of Medical Oncology and Integrative Oncology, sponsored by State University of New York at Buffalo.
NCT05356182 is a NA study of Medical Oncology and Integrative Oncology that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 30 participants, below the 253-participant average among 3 other Medical Oncology trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05356182, a NA study of Medical Oncology and Integrative Oncology, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The main idea of this study is that a low protein diet may alter the environment surrounding the tumor, enhancing the body's immune response leading to greater anticancer effects of treatment. This study intends to use a low-protein diet as a tool to enhance the immune response generated by immune check point inhibitor treatments.
Primary Outcome
Change in blood urea nitrogen (BUN) from baseline to post-intervention (following 3 cycles of treatment) will be measured to assess adherence of following the diet intervention.
Conditions Studied
Interventions
- OTHER Diet
Study Locations (1)
New York
- University at Buffalo / Great Lakes Cancer Care - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-05-04 |
| Est. Completion | 2027-02 |
| Phase | NA |
What NCT05356182 shows while recruiting
NCT05356182 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 253-participant average among 3 other Medical Oncology trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Medical Oncology appearing as the primary indexed condition, and to 1 intervention - of which Diet is the first listed.
NCT05356182 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05356182 about?
NCT05356182 is a clinical study titled "A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies". The main idea of this study is that a low protein diet may alter the environment surrounding the tumor, enhancing the body's immune response leading to greater anticancer effects of treatment. This study intends to use a low-protein diet as a tool to enhance the immune response generated by immune c...
What is the current status of trial NCT05356182?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-05-04. Estimated completion is 2027-02.
What conditions does trial NCT05356182 study?
This clinical trial studies the following conditions: Medical Oncology, Integrative Oncology, Medical Nutrition Therapy.
What interventions are being tested in trial NCT05356182?
The interventions under investigation include: Diet (OTHER).
Who is sponsoring clinical trial NCT05356182?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05356182 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medical Oncology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy
RECRUITING · NA
-
Ezra Faster Scan Study
COMPLETED
-
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI